AMIKACIN FOR TREATMENT OF INFECTIONS IN PATIENTS WITH MALIGNANT DISEASES

被引:24
作者
BODEY, GP [1 ]
RODRIGUEZ, V [1 ]
VALDIVIESO, M [1 ]
FELD, R [1 ]
机构
[1] UNIV TEXAS,MD ANDERSON HOSP & TUMOR INST,CTR CANC,DEPT DEV THERAPEUTICS,HOUSTON,TX 77025
关键词
D O I
10.1093/infdis/135.Supplement_2.S421
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
引用
收藏
页码:S421 / S427
页数:7
相关论文
共 16 条
[1]  
BODEY GP, 1966, CANCER-AM CANCER SOC, V19, P781, DOI 10.1002/1097-0142(196606)19:6<781::AID-CNCR2820190607>3.0.CO
[2]  
2-U
[3]  
BODEY GP, 1972, CANCER-AM CANCER SOC, V29, P1697, DOI 10.1002/1097-0142(197206)29:6<1697::AID-CNCR2820290638>3.0.CO
[4]  
2-K
[5]   PHARMACOLOGY OF AMIKACIN IN HUMANS [J].
BODEY, GP ;
VALDIVIESO, M ;
FELD, R ;
RODRIGUEZ, V .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1974, 5 (05) :508-512
[6]   SIGNIFICANCE OF FEVER IN NEOPLASTIC DISEASE [J].
BROWDER, AA ;
PETERSDORF, RG ;
HUFF, JW .
ANNALS OF INTERNAL MEDICINE, 1961, 55 (06) :932-+
[7]   CAUSES OF DEATH IN PATIENTS WITH MALIGNANT LYMPHOMA [J].
FELD, R ;
BODEY, GP ;
RODRIGUEZ, V ;
LUNA, M .
AMERICAN JOURNAL OF THE MEDICAL SCIENCES, 1974, 268 (02) :97-106
[8]  
GOVE DA, 1955, ASSAY METHODS ANTIBI, P188
[9]  
INAGAKI J, 1974, CANCER-AM CANCER SOC, V33, P568, DOI 10.1002/1097-0142(197402)33:2<568::AID-CNCR2820330236>3.0.CO
[10]  
2-2